A recent study in SMARCB1, a potent tumor suppressor with loss of expression, especially in certain rhabdoid tumor types and which is a core subunit of the SWI/SNF complex, showed persistent activation of AKT in SMARCB1-deficient tumor cells, contributing to survival and proliferation. Here, SMARCA1 is linked to neoplasm.